Abstract
1. A group of 72 human subjects were studied with respect to the immune reactions of their blood and sera to Types I, II and III pneumococci and to 4 other types (V, VI, VIII and IX) previously included in Group IV. 2. The same general relationships were observed for all of these types as were previously demonstrated for Types I, II and III. Each type was specific in relation to the bactericidal action of normal human blood and the protective action of normal human serum. 3. The frequency with which pneumococcidal action for any pair of types was present for both or absent for both in the same blood samples was slightly greater than that calculated from the frequencies with which each of the types was killed separately. 4. No closer correlation could be demonstrated between the reaction of the blood of these subjects to Types II and V or between Types III and VIII pneumococci, types related in their reaction with artificially prepared immune sera, than was observed between unrelated strains.
Full Text
The Full Text of this article is available as a PDF (733.0 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Avery O. T. A FURTHER STUDY ON THE BIOLOGIC CLASSIFICATION OF PNEUMOCOCCI. J Exp Med. 1915 Dec 1;22(6):804–819. doi: 10.1084/jem.22.6.804. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cooper G., Edwards M., Rosenstein C. THE SEPARATION OF TYPES AMONG THE PNEUMOCOCCI HITHERTO CALLED GROUP IV AND THE DEVELOPMENT OF THERAPEUTIC ANTISERUMS FOR THESE TYPES. J Exp Med. 1929 Feb 28;49(3):461–474. doi: 10.1084/jem.49.3.461. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cooper G., Rosenstein C., Walter A., Peizer L. THE FURTHER SEPARATION OF TYPES AMONG THE PNEUMOCOCCI HITHERTO INCLUDED IN GROUP IV AND THE DEVELOPMENT OF THERAPEUTIC ANTISERA FOR THESE TYPES. J Exp Med. 1932 Mar 31;55(4):531–554. doi: 10.1084/jem.55.4.531. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Finland M., Sutliff W. D. SPECIFIC CUTANEOUS REACTIONS AND CIRCULATING ANTIBODIES IN THE COURSE OF LOBAR PNEUMONIA : I. CASES RECEIVING NO SERUM THERAPY. J Exp Med. 1931 Oct 31;54(5):637–652. doi: 10.1084/jem.54.5.637. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Robertson O. H., Cornwell M. A. A STUDY OF THE RESISTANCE OF NORMAL HUMAN BEINGS TO RECENTLY ISOLATED STRAINS OF PATHOGENIC PNEUMOCOCCI. J Exp Med. 1930 Jul 31;52(2):267–277. doi: 10.1084/jem.52.2.267. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Robertson O. H., Sia R. H. STUDIES ON PNEUMOCOCCUS GROWTH INHIBITION : VII. THE RELATION OF OPSONINS TO NATURAL RESISTANCE AGAINST PNEUMOCOCCUS INFECTION. J Exp Med. 1927 Jul 31;46(2):239–262. doi: 10.1084/jem.46.2.239. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sugg J. Y., Gaspari E. L., Fleming W. L., Neill J. M. STUDIES ON IMMUNOLOGICAL RELATIONSHIPS AMONG THE PNEUMOCOCCI : I. A VIRULENT STRAIN OF PNEUMOCOCCUS WHICH Is IMMUNOLOGICALLY RELATED TO, BUT NOT IDENTICAL WITH TYPICAL STRAINS OF TYPE III PNEUMOCOCCI. J Exp Med. 1928 May 31;47(6):917–931. doi: 10.1084/jem.47.6.917. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sutliff W. D., Finland M. ANTIPNEUMOCOCCIC IMMUNITY REACTIONS IN INDIVIDUALS OF DIFFERENT AGES. J Exp Med. 1932 May 31;55(6):837–852. doi: 10.1084/jem.55.6.837. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ward H. K. OBSERVATIONS ON THE PHAGOCYTOSIS OF THE PNEUMOCOCCUS BY HUMAN WHOLE BLOOD : I. THE NORMAL PHAGOCYTIC TITRE, AND THE ANTI-PHAGOCYTIC EFFECT OF THE SPECIFIC SOLUBLE SUBSTANCE. J Exp Med. 1930 Apr 30;51(5):675–684. doi: 10.1084/jem.51.5.675. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Webster L. T., Hughes T. P. THE EPIDEMIOLOGY OF PNEUMOCOCCUS INFECTION : THE INCIDENCE AND SPREAD OF PNEUMOCOCCI IN THE NASAL PASSAGES AND THROATS OF HEALTHY PERSONS. J Exp Med. 1931 Mar 31;53(4):535–552. doi: 10.1084/jem.53.4.535. [DOI] [PMC free article] [PubMed] [Google Scholar]